The role of quetiapine extended release in the treatment of bipolar depression
MA Cristancho, ME Thase - Advances in therapy, 2010 - Springer
Bipolar disorder is a common, recurrent, and chronic condition associated with significant
morbidity and reduced longevity mainly due to the depressive pole of the illness. Despite the …
morbidity and reduced longevity mainly due to the depressive pole of the illness. Despite the …
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo …
M Liebowitz, RW Lam, U Lepola, C Datto… - Depression and …, 2010 - Wiley Online Library
Background: Primary objective: evaluate the efficacy (time to recurrence of depressive
symptoms) of once daily extended release quetiapine fumarate (quetiapine XR) as …
symptoms) of once daily extended release quetiapine fumarate (quetiapine XR) as …
[HTML][HTML] A Randomized, Double-Blind, Positive-Controlled, Multicenter Clinical Trial on the Efficacy and Safety of ShuganJieyu Capsule and St. John's Wort for Major …
Y Xiang, L Wang, P Gu, C Wang, Y Tian, W Shi… - International Journal of …, 2023 - Springer
Previous studies have found the effect of ShuganJieyu capsule and St. John's wort on the
treatment of depression and explored their potential benefits for somatic symptoms, while …
treatment of depression and explored their potential benefits for somatic symptoms, while …
Investigational drugs for treating major depressive disorder
A Dhir - Expert Opinion on Investigational Drugs, 2017 - Taylor & Francis
Introduction: Treatment of patients suffering from major depression could be highly
challenging for psychiatrists. Intractability as well as relapse is commonly seen among these …
challenging for psychiatrists. Intractability as well as relapse is commonly seen among these …
Agomelatine effectiveness, tolerability, and impact on anhedonia in major depression: a pooled analysis
M di Giannantonio, C Montemitro… - Journal of Clinical …, 2019 - journals.lww.com
Downloaded from by BhDMf5ePHKbH4TTImqenVA+ lpWIIBvonhQl60EtgtdlLYrLzSPu+
hUapVK5dvms8 on 11/28/2023 parameters were presented as mean±SD, and qualitative …
hUapVK5dvms8 on 11/28/2023 parameters were presented as mean±SD, and qualitative …
Post‐marketing surveillance of quetiapine fumarate extended‐release tablets in patients with bipolar depression
T Kishi, N Iwata, H Irie, M Aikawa - Neuropsychopharmacology …, 2024 - Wiley Online Library
Aim This study aimed to verify the real‐world efficacy and safety of quetiapine fumarate
extended‐release tablets (Bipresso® 50 mg and 150 mg; marketing authorization holder is …
extended‐release tablets (Bipresso® 50 mg and 150 mg; marketing authorization holder is …
A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I)
M Bauer, N Philips, W Chang, B Olausson… - J Clin …, 2010 - psychiatrist.com
Objective: The aim of this study was to compare the efficacy and tolerability of quetiapine
and lithium monotherapy with that of placebo for a major depressive episode in bipolar …
and lithium monotherapy with that of placebo for a major depressive episode in bipolar …
The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies
ZJ Zhang, WH Kang, Q Li, QR Tan - Journal of psychiatric research, 2007 - Elsevier
Our previous study has shown the beneficial effects of the herbal medicine called Free and
Easy Wanderer Plus (FEWP) as adjunctive therapy with carbamazepine (CBZ) in the 12 …
Easy Wanderer Plus (FEWP) as adjunctive therapy with carbamazepine (CBZ) in the 12 …
Divalproex extended-release in acute bipolar II depression
PW Wang, C Nowakowska, RA Chandler, SJ Hill… - Journal of affective …, 2010 - Elsevier
BACKGROUND: Divalproex extended-release (divalproex-ER) is effective in acute mania,
and limited data suggest divalproex may have efficacy in acute bipolar depression …
and limited data suggest divalproex may have efficacy in acute bipolar depression …
Personalized (N-of-1) trials for depression: a systematic review
IM Kronish, M Hampsey, L Falzon… - Journal of clinical …, 2018 - journals.lww.com
Purpose/Background: Personalized (N-of-1) trials are single-patient, crossover-design trials
that may be useful for personalizing the selection of depression treatments. We conducted a …
that may be useful for personalizing the selection of depression treatments. We conducted a …